Analyze Diet
New Zealand veterinary journal2015; 64(2); 125-134; doi: 10.1080/00480169.2015.1096853

The first reported outbreak of equine herpesvirus myeloencephalopathy in New Zealand.

Abstract: On 9 January 2014 (Day 0) a mare from a stud farm in the Waikato region presented with urinary incontinence without pyrexia. Over the following 33 days 15 mares were clinically affected with neurological signs. All but one mare had a foal at foot. The most commonly observed clinical signs were hind limb paresis and ataxia. In some cases recumbency occurred very early in the course of disease and seven mares were subject to euthanasia for humane reasons. Results: Equid herpesvirus (EHV) type 1 was detected using PCR in various tissues collected post mortem from two mares with neurological signs. DNA sequencing data from the DNA polymerase gene of the virus showed a nucleotide transition at position 2254, a mutation encoding amino acid D752 that is highly associated with the neuropathogenic genotype of EHV-1. In total 12/15 mares were confirmed positive for EHV-1 on PCR. Results from a virus neutralisation test and ELISA on paired serum samples, and PCR on whole blood and nasal swabs, indicated that of four paddocks in a high-risk area where a cluster of cases had occurred, 20/21 (95%) horses were likely to have been exposed or were confirmed infected with EHV-1. Subsequent to the outbreak two mares aborted, one at 9 months and one at 10 months of gestation. The cause of abortion was confirmed as EHV-1 with the same genotype as that involved in the outbreak. Methods: Equine herpesvirus myeloencephalopathy. Conclusions: The outbreak described shows the considerable impact that can occur in outbreaks of equine herpesvirus myeloencephalopathy in New Zealand. Early biosecurity controls not only reduced the effect on the farm but mitigated the potential for the virus to spread to other horse enterprises.
Publication Date: 2015-10-29 PubMed ID: 26414406DOI: 10.1080/00480169.2015.1096853Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study revolves around an outbreak of equine herpesvirus myeloencephalopathy that first appeared in New Zealand in 2014. On a stud farm, 15 mares showed neurological symptoms with tests revealing that 80% tested positive to a potent form of the herpesvirus that can cause severe neural damage. The outbreak had significant impacts, resulting in multiple euthanasia and abortions, demonstrating the severity and implications of herpesvirus myeloencephalopathy in equine populations in New Zealand.

Research Background and Scope

  • The outbreak began on 9th January 2014 when a mare from a stud farm in Waikato, New Zealand presented signs of urinary incontinence without any fever.
  • Over the next 33 days, 15 mares became clinically affected with neurological signs, with all but one having a foal at foot. The most common signs were hind limb paresis (partial loss of movement) and ataxia (lack of muscle control).

Scientific Findings and Results

  • A highly potent form of equine herpesvirus (EHV) type 1 was detected in various tissues collected post mortem from two mares.
  • The DNA sequencing data from the polymerase gene of the virus showed a nucleotide transition at position 2254. This particular mutation encodes amino acid D752, which is highly linked with the neuropathogenic genotype of EHV-1.
  • Out of the 15 mares affected, 12 were confirmed positive for EHV-1 through PCR (Polymerase Chain Reaction) testing.
  • Furthermore, results from virus neutralisation tests, ELISA on paired serum samples, whole blood and nasal swabs confirmed that 95% of the horses from four paddocks were likely exposed or infected with EHV-1.
  • Following the outbreak, two mares aborted – one at nine months and another at 10 months. The cause of the abortion was confirmed as EHV-1, the same genotype involved in the outbreak.

Conclusions and Recommendations

  • The outbreak demonstrates the massive impact that equine herpesvirus myeloencephalopathy can have on equine populations in New Zealand.
  • Early diagnosis and biosecurity measures not only helped reduce the outbreak’s effect on the farm, but also prevented the virus from spreading to other horse enterprises.
  • These findings highlight the need for stringent monitoring, effective biosecurity measures and regular testing in the equine industry to prevent and address such outbreaks promptly.

Cite This Article

APA
McFadden AM, Hanlon D, McKenzie RK, Gibson I, Bueno IM, Pulford DJ, Orr D, Dunowska M, Stanislawek WL, Spence RP, McDonald WL, Munro G, Mayhew IG. (2015). The first reported outbreak of equine herpesvirus myeloencephalopathy in New Zealand. N Z Vet J, 64(2), 125-134. https://doi.org/10.1080/00480169.2015.1096853

Publication

ISSN: 0048-0169
NlmUniqueID: 0021406
Country: England
Language: English
Volume: 64
Issue: 2
Pages: 125-134

Researcher Affiliations

McFadden, A M J
  • a Ministry for Primary Industries, Investigation and Diagnostic Centre , 66 Ward Street, Wallaceville, Upper Hutt 5018 , New Zealand.
Hanlon, D
  • b Matamata Veterinary Services Ltd , 26 Tainui Street, Matamata 3400 , New Zealand.
McKenzie, R K
  • b Matamata Veterinary Services Ltd , 26 Tainui Street, Matamata 3400 , New Zealand.
Gibson, I
  • c New Zealand Veterinary Pathology , Hamilton , New Zealand.
Bueno, I M
  • a Ministry for Primary Industries, Investigation and Diagnostic Centre , 66 Ward Street, Wallaceville, Upper Hutt 5018 , New Zealand.
Pulford, D J
  • a Ministry for Primary Industries, Investigation and Diagnostic Centre , 66 Ward Street, Wallaceville, Upper Hutt 5018 , New Zealand.
Orr, D
  • a Ministry for Primary Industries, Investigation and Diagnostic Centre , 66 Ward Street, Wallaceville, Upper Hutt 5018 , New Zealand.
Dunowska, M
  • d Institute of Veterinary, Animal and Biomedical Sciences, Massey University , Palmerston North 4442 , New Zealand.
Stanislawek, W L
  • a Ministry for Primary Industries, Investigation and Diagnostic Centre , 66 Ward Street, Wallaceville, Upper Hutt 5018 , New Zealand.
Spence, R P
  • a Ministry for Primary Industries, Investigation and Diagnostic Centre , 66 Ward Street, Wallaceville, Upper Hutt 5018 , New Zealand.
McDonald, W L
  • a Ministry for Primary Industries, Investigation and Diagnostic Centre , 66 Ward Street, Wallaceville, Upper Hutt 5018 , New Zealand.
Munro, G
  • a Ministry for Primary Industries, Investigation and Diagnostic Centre , 66 Ward Street, Wallaceville, Upper Hutt 5018 , New Zealand.
Mayhew, I G
  • d Institute of Veterinary, Animal and Biomedical Sciences, Massey University , Palmerston North 4442 , New Zealand.

MeSH Terms

  • Animals
  • Disease Outbreaks / veterinary
  • Encephalomyelitis / epidemiology
  • Encephalomyelitis / veterinary
  • Encephalomyelitis / virology
  • Female
  • Herpesviridae Infections / veterinary
  • Herpesvirus 1, Equid
  • Horse Diseases / epidemiology
  • Horse Diseases / virology
  • Horses

Citations

This article has been cited 8 times.
  1. Barbosa JD, Lins AMC, Bomjardim HDA, Silveira NDSES, Barbosa CC, Beuttemmuller EA, Brito MF, Salvarani FM. Equine Herpesvirus Type 1 Myeloencephalitis in the Brazilian Amazon.. Animals (Basel) 2022 Dec 23;13(1).
    doi: 10.3390/ani13010059pubmed: 36611668google scholar: lookup
  2. Price D, Barnum S, Mize J, Pusterla N. Investigation of the Use of Non-Invasive Samples for the Molecular Detection of EHV-1 in Horses with and without Clinical Infection.. Pathogens 2022 May 13;11(5).
    doi: 10.3390/pathogens11050574pubmed: 35631095google scholar: lookup
  3. Carvelli A, Nielsen SS, Paillot R, Broglia A, Kohnle L. Clinical impact, diagnosis and control of Equine Herpesvirus-1 infection in Europe.. EFSA J 2022 Apr;20(4):e07230.
    doi: 10.2903/j.efsa.2022.7230pubmed: 35414834google scholar: lookup
  4. Nielsen SS, Alvarez J, Bicout DJ, Calistri P, Canali E, Drewe JA, Garin-Bastuji B, Gonzales Rojas JL, Gortázar C, Herskin M, Michel V, Miranda Chueca MÁ, Roberts HC, Padalino B, Pasquali P, Spoolder H, Ståhl K, Calvo AV, Viltrop A, Winckler C, Carvelli A, Paillot R, Broglia A, Kohnle L, Baldinelli F, Van der Stede Y. Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): infection with Equine Herpesvirus-1.. EFSA J 2022 Jan;20(1):e07036.
    doi: 10.2903/j.efsa.2022.7036pubmed: 35035581google scholar: lookup
  5. Pusterla N, Barnum S, Miller J, Varnell S, Dallap-Schaer B, Aceto H, Simeone A. Investigation of an EHV-1 Outbreak in the United States Caused by a New H(752) Genotype.. Pathogens 2021 Jun 13;10(6).
    doi: 10.3390/pathogens10060747pubmed: 34199153google scholar: lookup
  6. Oladunni FS, Horohov DW, Chambers TM. EHV-1: A Constant Threat to the Horse Industry.. Front Microbiol 2019;10:2668.
    doi: 10.3389/fmicb.2019.02668pubmed: 31849857google scholar: lookup
  7. Garvey M, Lyons R, Hector RD, Walsh C, Arkins S, Cullinane A. Molecular Characterisation of Equine Herpesvirus 1 Isolates from Cases of Abortion, Respiratory and Neurological Disease in Ireland between 1990 and 2017.. Pathogens 2019 Jan 15;8(1).
    doi: 10.3390/pathogens8010007pubmed: 30650561google scholar: lookup
  8. Matczuk AK, Skarbek M, Jackulak NA, Bażanów BA. Molecular characterisation of equid alphaherpesvirus 1 strains isolated from aborted fetuses in Poland.. Virol J 2018 Dec 3;15(1):186.
    doi: 10.1186/s12985-018-1093-5pubmed: 30509297google scholar: lookup